It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
Author
Alves, Carla L 1
; Ehmsen Sidse 2
; Terp, Mikkel G 1 ; Portman, Neil 3 ; Tuttolomondo Martina 1
; Gammelgaard, Odd L 1
; Hundebøl, Monique F 1 ; Kaminska Kamila 4 ; Johansen, Lene E 1 ; Bak, Martin 5
; Honeth Gabriella 4 ; Bosch, Ana 4 ; Lim Elgene 3
; Ditzel, Henrik J 6
1 University of Southern Denmark, Department of Cancer and Inflammation Research, Institute of Molecular Medicine, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
2 University of Southern Denmark, Department of Cancer and Inflammation Research, Institute of Molecular Medicine, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170); Institute of Clinical Research, Odense University Hospital, Department of Oncology, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013)
3 Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924); University of New South Wales Sydney, St. Vincent’s Clinical School, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
4 Lund University, Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
5 Sydvestjysk Sygehus, Department of Pathology, Esbjerg, Denmark (GRID:grid.414576.5) (ISNI:0000 0001 0469 7368)
6 University of Southern Denmark, Department of Cancer and Inflammation Research, Institute of Molecular Medicine, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170); Institute of Clinical Research, Odense University Hospital, Department of Oncology, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013); Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013)







1 University of Southern Denmark, Department of Cancer and Inflammation Research, Institute of Molecular Medicine, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
2 University of Southern Denmark, Department of Cancer and Inflammation Research, Institute of Molecular Medicine, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170); Institute of Clinical Research, Odense University Hospital, Department of Oncology, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013)
3 Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924); University of New South Wales Sydney, St. Vincent’s Clinical School, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
4 Lund University, Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
5 Sydvestjysk Sygehus, Department of Pathology, Esbjerg, Denmark (GRID:grid.414576.5) (ISNI:0000 0001 0469 7368)
6 University of Southern Denmark, Department of Cancer and Inflammation Research, Institute of Molecular Medicine, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170); Institute of Clinical Research, Odense University Hospital, Department of Oncology, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013); Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013)
Publication year
2021
Publication date
2021
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2573124371
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.